Drug‐Induced Liver Injury by Selective Androgenic Receptor Modulators

Selective androgenic receptor modulators (SARMs) have not been approved by the U.S. Food and Drug Administration but they are heavily promoted as alternatives to androgenic anabolic steroids. We present two cases of liver injury associated with SARMs.

Detalles Bibliográficos
Autores principales: Flores, Joan Ericka, Chitturi, Shivakumar, Walker, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049679/
https://www.ncbi.nlm.nih.gov/pubmed/32140660
http://dx.doi.org/10.1002/hep4.1456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049679/
https://www.ncbi.nlm.nih.gov/pubmed/32140660
http://dx.doi.org/10.1002/hep4.1456

Ejemplares similares